“Ten FACTS”
The International Congress of the Royal College of Psychiatrists is underway in Edinburgh. Yesterday’s “education” drew to a close with this session: All ‘FACTS’ were provided by Paid Opinion Leaders. … Continue reading “Ten FACTS”
Tag: Sameer Jauhar
S Y M B O L I C
“Real science”, the Academic argued, should be “based on what is considered credible.” The Academic continued: “This is is one of the ‘Rules of Science’ and is necessary if we are to … Continue reading S Y M B O L I C
“Esketamine is approved in Europe”
The BMJ has published this News report, the full article can be accessed here.
Ketamine: “lost in translation?”
Last month I shared a BMJ Editorial on Ketamine by Dr Sameer Jauhar and Dr Paul Morrison. Since then there have been a number of published BMJ responses and replies. … Continue reading Ketamine: “lost in translation?”
“We should cautiously welcome this new therapeutic option”
There has long been awareness of the effects of Ketamine use among those who have taken it unprescribed. Given the lack of long term data on this specific “new therapeutic … Continue reading “We should cautiously welcome this new therapeutic option”
Position statement: frequency of withdrawal reactions
Following the publication of the Royal College of Psychiatrists Position Statement on antidepressants and depression there was widespread news coverage supported by Expert Statements by Professor Allan Young and Professor … Continue reading Position statement: frequency of withdrawal reactions
“uncritical partisan narrative”
In a previous post I shared this paper: The declarations of interest were given as follows: I have written the following open letter to the lead author: Sent: 22 May … Continue reading “uncritical partisan narrative”
“Antidepressants, withdrawal and addiction: where are we now?”
This perspective has just been published in the Journal of Psychopharmacology. My brief response to one of the authors can be read here, alongside further details of the competing interests of … Continue reading “Antidepressants, withdrawal and addiction: where are we now?”